X. Viñolas

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
X. Viñolas, Xavier Vinolas, Xavier Viñolas, X Viñolas, X Vinolas, X. Vinolas
Publication record
130 papers · 2,121 citations · H-index 20

PAPERS

Impact of Body Mass Index in the Cardioverter Efficacy of Amiodarone in Persistent Atrial Fibrillation
20243 citationsauthor #7
Amplified sinus-P-wave analysis predicts outcomes of cryoballoon ablation in patients with persistent and long-standing persistent atrial fibrillation: A multicentre study
20233 citationsauthor #20
CI-452769-2 PERFORMANCE OF LEADLESS PACEMAKERS IN EXTENDED FOLLOW-UP: 5 YEAR RESULTS FROM THE MICRA VR TRANSCATHETER PACING SYSTEM POST-APPROVAL REGISTRY
20230 citationsauthor #10
Influence of body mass index on recurrence of atrial fibrillation after electrical cardioversion
20235 citationsauthor #5
Creating value in patient-centred care by aligning the supply chain with service provision: Experiences with RITMOCORE
20230 citationsauthor #2
Impact on early patient mobilization of the use of a single vascular closure device in patients undergoing leadless pacemaker implantation.
20220 citationsauthor #6
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide
20229 citationsauthor #57
Distinct spectral dynamics of implanted cardiac defibrillator signals in spontaneous termination of polymorphic ventricular tachycardia and fibrillation in patients with electrical and structural diseases.
20221 citationsauthor #8
Spatial Distribution of Calcium Sparks Determines Their Ability to Induce Afterdepolarizations in Human Atrial Myocytes
202218 citationsauthor #10
Remote monitoring in a patient with multiple leadless pacemakers
20212 citationsauthor #8
Easily available ECG and echocardiographic parameters for prediction of left atrial remodeling and atrial fibrillation recurrence after pulmonary vein isolation: A multicenter study
202113 citationsauthor #20
Influence of sex on intracellular calcium homoeostasis in patients with atrial fibrillation
202128 citationsauthor #14
Atrial Fibrillation Originating in the Inferior Vena Cava
20213 citationsauthor #9
Single- vs dual-chamber ICDs to prevent from inappropriate shocks: the debate is still alive
20210 citationsauthor #6
Determinants of fibrotic atrial cardiomyopathy in atrial fibrillation. A multicenter observational study of the RETAC (reseau européen de traîtement d’arrhythmies cardiaques)-group
202112 citationsauthor #9
Improvement in Atrial Fibrillation-Related Symptoms After Cardioversion: Role of NYHA Functional Class and Maintenance of Sinus Rhythm
20219 citationsauthor #5
Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data
20219 citationsauthor #51
Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data
20219 citationsauthor #1068
Pharmacological Cardioversion after Pre-Treatment with Antiarrythmic Drugs Prior to Electrical Cardioversion in Persistent Atrial Fibrillation: Impact on Maintenance of Sinus Rhythm
20216 citationsauthor #2
Long‐Term Outcomes Among a Nationwide Cohort of Patients Using an Implantable Cardioverter‐Defibrillator: UMBRELLA Study Final Results
20208 citationsauthor #31
Sex-Specific Ventricular Arrhythmias and Mortality in Cardiac Resynchronization Therapy Recipients.
20209 citationsauthor #9
Predictors of adoption and impact of evidence-based programming on the incidence of implantable cardioverter-defibrillator therapies.
20201 citationsauthor #10
Rate, Time Course, and Predictors of Implantable Cardioverter Defibrillator Infections: An Analysis From the SIMPLE Trial
20202 citationsauthor #8
Long‐Term Outcomes Among a Nationwide Cohort of Patients Using an Implantable Cardioverter‐Defibrillator: UMBRELLA Study Final Results
20208 citationsauthor #9
Performance of the Micra cardiac pacemaker in nonagenarians.
202011 citationsauthor #11
Utility of Amiodarone Pre-Treatment as a Facilitator of the Acute Success of Electrical Cardioversion in Persistent Atrial Fibrillation
20206 citationsauthor #2
Rendimiento del marcapasos cardiaco Micra en nonagenarios
202012 citationsauthor #11
Diagnosis‐to‐ablation time in atrial fibrillation: A modifiable factor relevant to clinical outcome
201945 citationsauthor #14
Clinical characteristics of patients with sustained ventricular arrhythmias after sacubitril/valsartan initiation
201911 citationsauthor #3
Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF Registry
201947 citationsauthor #54
Effectiveness of single‐ vs dual‐coil implantable defibrillator leads: An observational analysis from the SIMPLE study
20199 citationsauthor #7
Defibrillation testing and clinical outcomes after implantable cardioverter-defibrillator implantation in patients in atrial fibrillation at the time of implant: An analysis from the SIMPLE trial.
20192 citationsauthor #9
Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis.
20193 citationsauthor #6
Personalized monitoring of electrical remodelling during atrial fibrillation progression via remote transmissions from implantable devices
201925 citationsauthor #11
Prognostic role of NYHA class in heart failure patients undergoing primary prevention ICD therapy
201925 citationsauthor #6
P5425Prognostic value of NYHA functional class in heart failure patients undergoing primary prevention implantable cardioverter defibrillator therapy
20190 citationsauthor #6
P443Primary Prevention Implantable Cardioverter Defibrillator (ICD): Should sex influence their indication?
20180 citationsauthor #9
P1199Role of electrocardiographic parameters to detect differente degrees of atrial fibrosis. Insights of the Substrate AF Study
20180 citationsauthor #6
Pacemaker‐mediated tachycardia in the absence of retrograde ventriculoatrial conduction: What is the mechanism?
20181 citationsauthor #5
P340Identification of clinical risk factors and biological markers associated with development of atrial low voltage substrate predisposing to atrial fibrillation. Substrate-AF-Study
20180 citationsauthor #6
Single-brand dual-chamber discriminators to prevent inappropriate shocks in patients implanted with prophylactic implantable cardioverter defibrillators: a propensity-weighted comparison of single- and dual-chamber devices
201811 citationsauthor #6
Comparison between endocardial and epicardial cardiac resynchronization in an experimental model of non-ischaemic cardiomyopathy
20186 citationsauthor #7
Left atrial geometry and outcome of atrial fibrillation ablation: results from the multicentre LAGO-AF study
201859 citationsauthor #14
P874Analysis of efficacy of event discrimination algorithm added to standard programming strategies based on cycle length and detection intervals in implantable defibrillator
20180 citationsauthor #9
P3453Survival and arrhythmic mortality among ischemic and non-ischemic heart failure patients undergoing ICD-only therapy for primary prevention strategy
20180 citationsauthor #7
1014Left atrial geometry and outcome of atrial fibrillation ablation: results from the multicenter LAGO-AF Study
20180 citationsauthor #13
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry
201820 citationsauthor #2057
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry
201820 citationsauthor #63
P2889The economic burden attributable to atrial fibrillation in nine European countries: perspectives from the GARFIELD-AF registry
20181 citationsauthor #13
Sedation strategies for defibrillation threshold testing: safety outcomes with anaesthesiologist compared to proceduralist-directed sedation an analysis from the SIMPLE study
20181 citationsauthor #13
P1228Individual discriminators contribution to the reduction of inappropriate therapies in implantable defibrillators
20180 citationsauthor #9
529Diagnostic-to-ablation Time in Atrial Fibrillation: A modifiable factor relevant to clinical outcome
20181 citationsauthor #14
SAFETY OUTCOMES WITH ANESTHESIOLOGIST DIRECTED SEDATION COMPARED TO NON-ANESTHESIOLOGIST FOR DEFIBRILLATION THRESHOLD TESTING
20170 citationsauthor #12
P1744Inappropriate therapies in primary prevention ICD patients with narrow QRS: dual or single chamber ICD? The question remains
20170 citationsauthor #7
Shock Reduction With Antitachycardia Pacing Before and During Charging for Fast Ventricular Tachycardias in Patients With Implantable Defibrillators.
20173 citationsauthor #5
3875Discriminators algorithm integrated into implantable defibrillator: diagnostic capacity analysis and impact in the reduction of inappropriate therapies
20170 citationsauthor #9
P1741Arrhythmic risk among ischemic and non-ischemic heart failure patients with narrow QRS: insigths from the umbrella registry
20170 citationsauthor #7
Implantable cardioverter-defibrillator therapy in hypertrophic cardiomyopathy: A SIMPLE substudy.
201717 citationsauthor #11
Etiology and Programming Effects on Shock Efficacy in ICD Recipients
20165 citationsauthor #5
Troponin levels after ICD implantation with and without defibrillation testing and their predictive value for outcomes: Insights from the SIMPLE trial.
201616 citationsauthor #7
Apical versus Non‐Apical Lead: Is ICD Lead Position Important for Successful Defibrillation?
201612 citationsauthor #12
Atrial Rate‐Responsive Pacing and Incidence of Sustained Atrial Arrhythmias in Patients with Implantable Cardioverter Defibrillators
201612 citationsauthor #10
Incidence of arrhythmias in a large cohort of patients with current implantable cardioverter-defibrillators in Spain: results from the UMBRELLA Registry.
201616 citationsauthor #4
Small‐Caliber Lead Failure After Generator Exchange
20163 citationsauthor #5
An Automatic Algorithm Based on Morphological Stability During Fast Ventricular Arrhythmias Predicts Successful Antitachycardia Pacing in ICD Patients: A Multicenter Study
20162 citationsauthor #6
16-73: Long term outcomes of cardiac resynchronization therapy with a defibrillator according to QRS duration in patients with left bundle branch block
20160 citationsauthor #5
[Status of cardiac resynchronization therapy in Catalonia, Spain: Results of the prospective multicentric study TRC-CAT].
20162 citationsauthor #5
A multicentric study of long-term rhythm patterns in heart rate
20162 citationsauthor #4
High‐Density Mapping of Counterclockwise to Clockwise Typical Atrial Flutter: Visualization of the Conduction Gap
20162 citationsauthor #4
Association of cardiac resynchronization therapy with the incidence of appropriate implantable cardiac defibrillator therapies in ischaemic and non-ischaemic cardiomyopathy
20164 citationsauthor #5
Wound haematoma following defibrillator implantation: incidence and predictors in the Shockless Implant Evaluation (SIMPLE) trial
201632 citationsauthor #6
Shock Reduction With Multiple Bursts of Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: A Multicenter Study
201527 citationsauthor #8
Gender Differences in Patients with Atrial Fibrillation Undergoing Electrical Cardioversion
201517 citationsauthor #2
Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).
2015244 citationsauthor #6
Usefulness of antitachycardia pacing in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
20152 citationsauthor #3
Abstract 17295: Effect of Atrial Rate-responsive Pacing in the Incidence of Sustained Atrial Arrhythmias in Patients With Implantable Cardioverter-defibrillators
20150 citationsauthor #10
Location of Accessory Pathways in WPW: What and How Should We Ablate
20140 citationsauthor #2
An Unusual Onset of Supraventricular Tachycardia with 2:1 Atrioventricular Block: What Is the Mechanism?
20140 citationsauthor #4
Clinical profile and incidence of ventricular arrhythmia in patients undergoing defibrillator generator replacement in Spain.
20146 citationsauthor #6
New Oral Anticoagulants vs Vitamin K Antagonists: Benefits for Health-Related Quality of Life in Patients with Atrial Fibrillation
201430 citationsauthor #2
[Predictors of reversion to sinus rhythm previous to electrical cardioversion in patients with persistent atrial fibrillation treated with anti-arrhythmic drugs].
20135 citationsauthor #1
Effects of Open‐Irrigated Radiofrequency Ablation Catheter Design on Lesion Formation and Complications: In Vitro Comparison of 6 Different Devices
201372 citationsauthor #8
Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study)
2013387 citationsauthor #5
Differential clinical characteristics and prognosis of intraventricular conduction defects in patients with chronic heart failure
201328 citationsauthor #31
Bundle branch block and QRS width in ICD patients. Morphology is more important than length
20130 citationsauthor #4
The rationale and design of the Shockless IMPLant Evaluation (SIMPLE) trial: a randomized, controlled trial of defibrillation testing at the time of defibrillator implantation.
201232 citationsauthor #5
Trends in the use of electrical cardioversion for atrial fibrillation: influence of major trials and guidelines on clinical practice
201213 citationsauthor #2
[Progress in cardiac electrophysiology and arrhythmias].
20120 citationsauthor #4
Interatrial blocks. A separate entity from left atrial enlargement: a consensus report.
2012341 citationsauthor #9
Integration of late-enhanced MRI and electroanatomical mapping for substrate ablation of poorly tolerated ventricular tachycardia.
20101 citationsauthor #4
Atrial tachycardia originating from the pulmonary vein: clinical, electrocardiographic, and differential electrophysiologic characteristics.
20104 citationsauthor #3
Abstracts: Associated risk in atrial fibrillation patients
20090 citationsauthor #10
Clinical effectiveness of antiarrhythmic treatment after electrical cardioversion in patients without structural heart disease.
20085 citationsauthor #2
[Clinical characteristics of patients with persistent atrial fibrillation referred for cardioversion: Spanish Cardioversion Registry (REVERSE)].
20084 citationsauthor #2
Changes in myocardial electrical impedance in human heart graft rejection
200818 citationsauthor #11
Predictors of success and effect of biphasic energy on electrical cardioversion in patients with persistent atrial fibrillation.
200724 citationsauthor #2
Monitoring Ectopic Activity
20070 citationsauthor #2
Heart Graft Rejection Assessed by Multi-Frequency Electrical Impedance: Human Results
20071 citationsauthor #7
[Clinical value of cardiovascular magnetic resonance imaging in the diagnostic work-up of patients with suspected arrhythmogenic right ventricular dysplasia].
20054 citationsauthor #7
A16-5 Automatic measurement of corrected qt interval in holter ECG as a marker of life-threatening arrhythmias in postmyocardial infarction patients
20030 citationsauthor #5

TIMELINE

1990 0 citations

1991 0 citations

1992 6 citations

1993 0 citations

1994 17 citations

1995 56 citations

1996 16 citations

1997 14 citations

1998 4 citations

1999 70 citations

2000 58 citations

2001 2 citations

2003 16 citations

2005 4 citations

2007 25 citations

2008 27 citations

2009 0 citations

2010 5 citations

2012 386 citations

2013 492 citations

2014 36 citations

2015 290 citations

2016 108 citations

2017 20 citations

2018 100 citations

2019 167 citations

2020 49 citations

2021 82 citations

2022 28 citations

2023 8 citations

2024 3 citations

X. Viñolas

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT